Niacin and niacinamide sales will expand through 2036, with dry form holding 57.0% of the form segment in 2026, driven by longer shelf life, ease of handling, and broad applicability across pharmaceutical and food industries. The market was valued at USD 1.30 billion in 2025 and is expected to reach USD 1.82 billion by 2036.